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Ateroskleroosi on tulehdustauti jota rasva-aineenvaihdunnan häiriö edesauttaa. Sen 
kardiometaboliset riskitekijät ja molekyylitason mekanismit tulevat ilmi jo lapsuudessa. 
 
Hyvä non-invasiivinen tutkimus ateroskleroosi muutosten monitorointiin on ultraääni. 
Kasvanut kaulavaltimosuonten  pinta- ja keskikerroksen paksuuntuminen on aikainen taudin 
muutos. Geneettinen profilointi ja genomin laajuiset assosiaatiotutkimukset ovat tuoneet 
lisävaloa sydän-ja verisuonitauteihin. 
Kyseisen tutkimuksen tarkoituksena oli etsiä geneettisen variaation (SNP) rooli geeneissä 
jotka ovat yliilmentyneet kolminkertaisesti kaulavaltimon ateroskleroottisissa plakeissa ja 
löytää uusia funktionaalisia geneettisiä muutoksia joilla olisi merkitystä ateroskleroosin 
ilmetymisessä varhaisessa iässä. 
 
Näytteet ja aineisto saatiin Cardiovascular young finns study ja Tampere vascular study 
potilasaineistosta. Kaulavaltimosuonten sisä-ja keskikerroksen paksuus (cIMT) mitattiin 
ultraäänellä ja yhteensä 2442 henkilöä genotyypitettiin. TVS aineistosta ateroskleroosisuonia 
verrattiin histologisesti normaaleihin suoniin. YFS aineiston 546 677 genotyypitetystä 
SNP:stä valittiin lisätutkimuksiin 235 geeniä. 
 
20 näistä olivat tilastollisesti merkityksellisiä cIMT kanssa. Geenit TBXAS1 ja CD36 ovat 
aikaisemmin assosioituneet ateroskleroosin kanssa. 
Tutkimuksen tulokset ovat alustavia, mutta näyttävät että 20 itsenäisellä geneettisellä 
variaatiolla on viitteellistä assosiaatiota ateroskleroosin subkliiniselle kehittymiselle. 
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Abstract 
 
Background: Atherosclerosis is lipid derived immune-inflammatory disease. 
Cardiometabolic risk factors of atherosclerosis and the molecular mechanisms responding to 
these risk factors in the artery wall are in place and start their effect soon after birth even 
cardiometabolic disorders can have roots already in utero. A good noninvasive way to monitor 
subclinical effects of atherosclerosis is to measure these indices by ultrasound technique. 
Increased carotid intima-media thickness (cIMT) and involvement of carotid artery plaques 
are markers of early structural atherosclerosis. Genetic profiling with the aid of genome-wide 
association studies has found novel variants associating with myocardial infarction and 
cardiovascular diseases.   
Objectives: The present study aimed to investigate the role of genetic variation (single 
nucleotide polymorphism, SNPs) in the genes over-expressed in carotid artery atherosclerotic 
lesions in the development of early atherosclerotic changes in the carotid artery wall and to 
find new functional genetic changes which affect the onset of cardiovascular diseases at early 
age. 
Subjects and methods: The study was based on the Cardiovascular Risk in Young Finns 
(YFS) and Tampere vascular study (TVS) samples and data. From YFS cIMT was measured 
by ultrasound. Altogether 2442 YFS participants (1123 males, 1319 females) were genotyped 
using a Illumina Human 670K BeadChip. TVS study samples (n=9 carotid atherosclerotic 
cases with histological AHA classification) and six histologically atherosclerotic free controls 
had transcriptomics data by using Illumina’s Sentrix Human-8 Expression BeadChip arrays 
containing probes for all known human genes (23.000 genes). 
Results: From the 546.677 successfully genotyped SNPs in YFS all the SNPs that were 
located in the 235 over expressed genes (fold change ≥ 3.0 as compared to non-atherosclerotic 
 2 
control vessels with p-value <0.05) of TVS samples or 5 kb upstream and downstream of the 
gene were selected for further analyses. These carotid artery expressed candidate genes 
contained altogether 2711 true-genotyped and 7120 imputed SNPs in YFS study. From this 
studied SNPs 20 were statistically suggestively associated with cIMT progression in YFS 
study. Two of the found SNPs located in genes TBXAS1 and CD36 and have been found 
before to have a significant association with atherosclerosis suggesting true positive results. 
Conclusion: The results of the present study are preliminary and showed that 20 individual 
genetic variants have a suggestive association with progression of subclinical atherosclerosis. 
However for confirmation of these results further studied are needed to replicate these 
findings with other independent cohorts.  
 
Keywords: Subclinical atherosclerosis, SNPs, GWA, genetic variation 
 
Introduction 
 
Atherosclerosis, the cause of myocardial infarction, stroke, and ischemic gangrene, is an 
immune-inflammatory disease (1) having several phases and modified lipid accumulation to 
artery wall. The development of atherosclerotic lesions is a slow process that involves several 
immunological factors, like macrophages and T-lymphocytes. During the pathologic process 
in the artery wall endothelium leukocyte adhesion molecules attract monocytes, which in turn 
convert into macrophages and clear up the oxidized LDL-particles to form lipid containing 
foam cells. Monocytes differentiated into foam-cells can eventually die which leads into the 
accumulation of modified cytotoxic lipids and cholesterol in the intima. In response to local 
antigens T-lymphocytes secrete pro-inflammatory cytokines and eventually, the artery 
becomes inflamed. The inflammation stimulates migration, proliferation of smooth-muscle 
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cells, and formation of fibrous tissue and causes the thickening of the artery wall. Intense 
inflammation can lead to proteolysis in the plaque and cause rupture and thrombus formation, 
which can lead up to ischemia, myocardial infarction or even sudden cardiac death. 
Atherosclerosis is a multifactorial disease. Both biochemical and physiological mechanisms 
for atherosclerosis are in place soon after birth, and it is convincingly shown that the disease 
process leading to atherosclerosis is already underway in childhood (2,3). 
 
Increased carotid intima-media thickness (cIMT), as assessed noninvasively by ultrasound, is 
considered a marker of structural atherosclerosis (4,5). In healthy adults (19-90 years) 
followed over 4 years, cIMT was shown to be an independent predictor of stroke, MI and 
death (6). Accelerated progression in IMT is a marker of atherosclerosis development that 
increases the risk of cardiovascular events (7). A recent meta-analysis revealed that an 
approximately 0,1 mm change in cIMT corresponds to an increase of 15% in the risk of 
myocardial infarction (8). 
 
The recent surge in genetic profiling with the aid of genome-wide association studies 
(GWASs) has found novel variants associating with myocardial infarction and coronary artery 
disease (9,10,11,12,13,14,15,16). These variants could be biomarkers themselves or point to 
circulating markers for further exploration (17). At present, only five SNPs associated with 
coronary artery disease in previous GWASs (rs10757274, rs1333049, rs6922269, rs501120 
and rs2943634) have been investigated for possible associations with subclinical 
atherosclerosis (18, 19, 20, 21, 22). Also, Hernesniemi et al. reported that the genetic profiling 
of 24 variants previously associated with the risk of CAD on a genome-wide -significant level 
(SNPs) did not improve risk stratification for subclinical atherosclerosis beyond conventional 
risk factors among healthy young adults. In the meta-analysis of GWAS data from nine 
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studies of common cIMT genome-wide significant associations between three regions and 
common cIMT was identified (23). The strongest association was for rs11781551, found on 
8q24 approximately 385 kb from ZHX2 gene.  The second association was for rs445925, 
located 2.3 kb from APOC1 on 19q13, a region that also includes APOE, APOC2, and APOC4.  
The third association was for rs6601530, located within the PINX1 gene on 8q23.1. No SNP 
achieved the significance threshold for follow up in the discovery analysis of internal cIMT 
(24). There has been a persistent, but weak relationship between sCD36 and IMT after 
correction of confounders, and it could have a potential to be an important marker for 
atherosclerosis (25). 
 
In this study we identified genes that were over expressed in atherosclerotic tissue obtained 
from carotid arteries in the Tampere Vascular study. From the genome wide association study 
(GWAS) made on the Young Finns Study participants we obtain the genotype data of the 
SNPs (single nucleotide polymorphisms) located in these over expressed genes for association 
studies. Our aim was to discover the genetic variation of the genes up-regulated in carotid 
plaque tissue and analyze their role as possible modifiers of the intima media thickness 
progression in the arterial wall.  
 
 
Subjects 
 
Tampere Vascular pilot Study (TVS)  
 
The atherosclerotic vascular sample set consists of femoral arteries, carotid arteries and 
abdominal aortas from patients participating in the on-going Tampere Vascular Study (26). 
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The patients had a polyvascular disease (i.e. at least two major arterial beds affected by 
atherosclerotic plaques as evidenced by 1) previous transient ischemic attack and 
atherosclerotic plaques in the cerebral vasculature or 2) coronary atherosclerosis as evidenced 
by previous MI or 3) angina pectoris and atherosclerotic plaques in coronary angiography or 
4) objectively verified peripheral arterial disease by ankle-brachial pressure index < 0.9 or 5) 
previous arterial surgery due to atherosclerosis or 6) angiographical demonstration of arterial 
plaques). In a histological study of atherosclerotic vessels, the atherosclerotic samples were 
classified as type V-VI according to the American Heart Association classification (AHA). 
Control samples were taken from internal thoracic arteries (ITA) from patients obligated to 
by-pass surgery due to coronary heart disease. The samples from ITA (internal thoracic 
artery) were removed from the distal end of the artery at the beginning of dissection and were 
verified histologically to have no atherosclerotic changes.  
 
The Cardiovascular Risk in Young Finns Study (YFS) 
 
The Cardiovascular Risk in Young Finns Study (YFS) is a follow-up study of atherosclerosis 
precursors in Finnish children and adolescents. The study has been carried out in all five 
Finnish university cities with medical schools (Helsinki, Kuopio, Oulu, Tampere, Turku) and 
in their rural surroundings. In the first cross-sectional study in 1980, altogether 4320 children 
and adolescents aged 3–18 years were randomly chosen from the national population register 
of these areas to produce a representative sample of Finnish children. Of these subjects, a total 
of 3596 boys and girls participated in the cross-sectional study in 1980. Since then the study 
cohort has participated in follow-up studies in 3-6 year intervals. The vascular ultrasound 
measurements of carotid intima media thickness (cIMT) were performed in 2001 and 2007 
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part of the 21-year and 27-year follow-ups. A total of 1,809 subjects had cIMT data both in 
2001 and 2007, and in addition 844 had cIMT measured either in 2001 or 2007 (27). 
 
Methods 
 
Genome wide expression analysis (GWE) of the TVS pilot samples 
 
The vascular samples used in GWE consist of atherosclerotic plaques from the following 
arterial sites: femoral artery (n=4), carotid artery (n=9) and abdominal aorta (n=7), and six 
control samples taken from internal thoracic arteries (ITA) during coronary artery by-pass 
surgery all together a total of 26 patients participating in Tampere Vascular Study (26). Of 
these patients, only two had polyvascular disease and all the rest had monovascular disease 
limited to the coronary vasculature. The analysis of the gene expression levels were made by 
using Illumina’s Sentrix Human-8 Expression BeadChip arrays containing probes for all 
known human genes (23.000 genes). The method has been described in more detail in Levula 
et al. (26). From the GWE analysis we selected genes that showed at least 3-fold increase 
(n=235, p-value <0.05) in expression in carotid arteries compared to ITAs for further studies.  
 
Genotyping and imputation of the YFS 
 
Genotyping was done for 2,556 samples using custom build Illumina Human 670k BeadChip 
at Welcome Trust Sanger Institute. Genotypes were called using Illuminus clustering 
algorithm. After quality control there were 2,442 samples and 546,677 genotyped SNPs 
available for further analysis (28). Genotype imputation was performed using MACH 1.0 
(29,30) and HapMap II CEU (release 22) samples as reference. Palindromic A/T and C/G 
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SNPs were removed before imputation. After imputation there were 2,543,887 imputed SNPs 
available. SNPs with squared correlation between imputed and true genotypes ≥ 0.30 were 
considered well imputed. 
 
Association studies of the YFS 
 
All the SNPs located in the over expressed (FC≥3.0, p-value <0.05) genes (plus 5 kb upstream 
and downstream) in plaque tissues obtained from carotid arteries were selected for further 
analyses. SNPs with MAF (minor allele frequency) ≥ 0.01 and p<0.01 were included in the 
further analysis. From each LD block we selected one SNP to represent the block by using the 
SPOT programme (31). As a result we had 73 independently associated SNPs. These SNPs 
were further analysed by using linear regression model (forward) adjusted for sex, BMI delta 
and principal components to control population stratification (26) in order to identify SNPs 
associated with changes in cIMT. 
 
 
Results  
 
In the GWE analysis of the TVS pilot samples 235 genes were ≥ 3 times up regulated in 
carotid plaque tissues as compared to healthy vascular tissue in Tampere Vascular study. In 
further analysis we studied the effect of the genetic variation of 2711 true-genotyped and 7120 
imputed SNPs of these genes on changes (progression) of carotid IMT between 2001 and 
2007 in the YFS population. The basic characteristics of the studied YFS population are 
shown in Table 1. In the Table 2 we show the SNPs that had a strongest suggestive evidence 
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for association with the progression of carotid the intima media thickness over the period of 
six years from 2001 to 2007 in the Young Finns study. 
 
	  
Discussion 
 
From the top 20 SNPs that we found, only two SNPs have been previously reported to have 
any significant association with atherosclerosis, rs41728 in TBXAS1 and rs3211883 in CD36 
suggesting true positive results. TBXAS1 is a member of the cytochrome P450 superfamily of 
enzymes this endoplasmic reticulum membrane protein catalyzes the conversion of 
prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet 
aggregation. The enzyme plays a role in several pathophysiological processes including 
hemostasis, cardiovascular disease, and stroke. The protein encoded by the CD36 gene is the 
fourth major glycoprotein of the platelet surface and serves as a receptor for anti-aggregator 
molecule, thrombospondin in platelets and various cell lines. Since thrombospondins are 
widely distributed proteins involved in a variety of adhesive processes, this protein may have 
important functions as a cell adhesion molecule. In addition variation in gene TBXAS1 has 
been associated with MI risk (study population, age 30-79 years, predominantly Caucasian 
population from western Washington State) (33), and CD36 with carotid atherosclerosis 
(Caucasian, age 30-60 years, from European countries) (25).  
 
A recent meta-analysis showed that an approximately 0,1 mm change in cIMT corresponds to 
an increase of 15% in the risk of myocardial infarction (34). Carotid IMT is an excellent 
surrogate phenotype for studying the development of subclinical atherosclerosis, but its result 
should be interpreted with caution as not all etiological factors are identical in the 
 9 
pathogenesis of coronary atherosclerosis. The results of the present study showed that 
individual polymorphisms do not have a substantial impact on cIMT. However, we restricted 
the analysis only on the genetic variation found on genes that were shown to be overexpressed 
in the carotid artery plaque tissue. Thus our results do not rule out the possibility that other 
genetic factors may affect intima media thickness and the changes in it.  
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Table 1. Characteristics of the Young Finns Study population. 
Note* weight change between years 2001 and 2007, Abbreviations: cIMT = carotid intima 
media thickness 
 
 
 
 
 
 
 
 
 
 
Variables  (N) Mean±SD Range 
Number of participants (male/female) 1641(920/721) - - 
Age in 2007, years  
Body mass index delta (kg/m2) * 
 
31,9 
0,963 
- 
cIMT 2001 (mm)  0,579±0,093 0,967 
cIMT 2007 (mm)  0,626±0,978 0,7 
Change in cIMT (mm)  
between 2001 and 2007 
 0,0465±0,0839 0,76 
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Table 2. Twenty top SNPs that showed the strongest suggestive association with the 
progression of intima media thickness in the Young Finns Study population over the period of 
6 years from 2001 to 2007.  
Rs number A1 Beta P-value Imputed* MAF Gene abbreviation 
rs3211883 T -0,018913 1,750E-04 1 0,10 CD36 
rs7201518 T -0,0114 2,020E-04 1 0,42 n/a 
rs7290147 C 0,010822 3,180E-04 1 0,43 CECR1 
rs11670330 A -0,011271 5,000E-04 1 0,32 C5AR1 
rs3827784 A -0,011195 6,090E-04 1 0,30 LY86 
rs17536527 C -0,010255 9,090E-04 1 0,47 n/a 
rs10924510 C 0,020311 1,764E-03 1 0,06 GPR137B 
rs6950163 C -0,014523 1,765E-03 1 0,12 SNX10 
rs1372319 G -0,010461 1,917E-03 0 0,26 LHFPL2 
rs7842 G 0,010009 2,133E-03 0 0,30 C3AR1 
rs11134606 C -0,013747 2,286E-03 1 0,16 DOCK2 
rs1127203 C -0,015393 2,860E-03 1 0,09 CA12 
rs11880785 A -0,021439 2,983E-03 1 0,04 n/a 
rs1769259 G 0,018001 3,262E-03 0 0,06 FBP1 
rs41728 G 0,010595 3,732E-03 0 0,21 TBXAS1 
rs9982242 G 0,027777 3,914E-03 1 0,03 ABCG1 
rs11785442 A -0,012789 4,111E-03 1 0,13 n/a 
rs12030938 G -0,014979 4,586E-03 1 0,11 CD53 
rs483159 A 0,010579 5,887E-03 1 0,17 n/a 
rs34004019 G -0,008071 7,215E-03 0 0,34 n/a 
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* 1 = SNP in question has been imputed. MAF=minor allele frequency. 
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